Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-19-009595
Filing Date
2019-08-14
Accepted
2019-08-14 16:38:28
Documents
53
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT biei_10q.htm 10-Q 945185
2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER biei_ex311.htm EX-31.1 12682
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CHIEF FINANCIAL OFFICER biei_ex312.htm EX-31.2 12785
4 CHIEF EXECUTIVE OFFICER CERTIFICATION PURSUANT TO 18 USC, SECTION 1350, AS ADOPT biei_ex321.htm EX-32.1 7937
5 CHIEF FINANCIAL OFFICER CERTIFICATION PURSUANT TO 18 USC, SECTION 1350, AS ADOPT biei_ex322.htm EX-32.2 7928
6 IMAGE biei_10q000.jpg GRAPHIC 4336
  Complete submission text file 0001654954-19-009595.txt   2833196

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT biei-20190630.xml EX-101.INS 411609
8 XBRL TAXONOMY EXTENSION SCHEMA biei-20190630.xsd EX-101.SCH 25231
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE biei-20190630_cal.xml EX-101.CAL 34509
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE biei-20190630_def.xml EX-101.DEF 74907
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE biei-20190630_lab.xml EX-101.LAB 160086
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biei-20190630_pre.xml EX-101.PRE 137470
Mailing Address P.O. BOX 25 JACKSON CENTER PA 16133
Business Address P.O. BOX 25 JACKSON CENTER PA 16133 724-633-7033
PREMIER BIOMEDICAL INC (Filer) CIK: 0001515740 (see all company filings)

EIN.: 272635666 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54563 | Film No.: 191027096
SIC: 2836 Biological Products, (No Diagnostic Substances)